Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Change in Acquisitions & Divestments (2020 - 2025)

Silo Pharma's Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $410300.0 for Q2 2025.

  • For Q2 2025, Change in Acquisitions & Divestments fell 58.93% year-over-year to $410300.0; the TTM value through Sep 2025 reached $1.3 million, down 61.37%, while the annual FY2024 figure was $1.1 million, 72.29% down from the prior year.
  • Change in Acquisitions & Divestments for Q2 2025 was $410300.0 at Silo Pharma, down from $905353.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $2.3 million in Q4 2023 and bottomed at -$62000.0 in Q3 2021.
  • The 4-year median for Change in Acquisitions & Divestments is $410300.0 (2025), against an average of $677973.2.
  • The largest annual shift saw Change in Acquisitions & Divestments plummeted 1340.0% in 2021 before it soared 502.01% in 2025.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at -$62000.0 in 2021, then skyrocketed by 3738.75% to $2.3 million in 2023, then crashed by 55.72% to $998931.0 in 2024, then crashed by 58.93% to $410300.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Change in Acquisitions & Divestments are $410300.0 (Q2 2025), $905353.0 (Q1 2025), and $998931.0 (Q2 2024).